American National Registered Investment Advisor’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $272K | Sell |
3,531
-80
| -2% | -$6.69K | 0.1% | 226 |
|
|
2021
Q4 | $319K | Sell |
3,611
-1
| -0% | -$83 | 0.11% | 212 |
|
|
2021
Q3 | $279K | Sell |
3,612
-10
| -0.3% | -$789 | 0.1% | 217 |
|
|
2021
Q2 | $302K | Sell |
3,622
-20
| -0.5% | -$1.58K | 0.11% | 212 |
|
|
2021
Q1 | $275K | Sell |
3,642
-3
| -0.1% | -$245 | 0.11% | 214 |
|
|
2020
Q4 | $320K | Sell |
3,645
-80
| -2% | -$6.34K | 0.13% | 181 |
|
|
2020
Q3 | $283K | Hold |
3,725
| – | – | 0.13% | 169 |
|
|
2020
Q2 | $459K | Hold |
3,725
| – | – | 0.23% | 128 |
|
|
2020
Q1 | $315K | Hold |
3,725
| – | – | 0.2% | 145 |
|
|
2019
Q4 | $315K | Hold |
3,725
| – | – | 0.16% | 178 |
|
|
2019
Q3 | $251K | Hold |
3,725
| – | – | 0.14% | 188 |
|
|
2019
Q2 | $319K | Hold |
3,725
| – | – | 0.18% | 168 |
|
|
2019
Q1 | $331K | Sell |
3,725
-10
| -0.3% | -$927 | 0.18% | 170 |
|
|
2018
Q4 | $318K | Hold |
3,735
| – | – | 0.2% | 152 |
|
|
2018
Q3 | $362K | Buy |
3,735
+450
| +14% | +$44.9K | 0.19% | 163 |
|
|
2018
Q2 | $309K | Hold |
3,285
| – | – | 0.15% | 211 |
|
|
2018
Q1 | $266K | Sell |
3,285
-65
| -2% | -$5.58K | 0.13% | 214 |
|
|
2017
Q4 | $299K | Hold |
3,350
| – | – | 0.14% | 211 |
|
|
2017
Q3 | $312K | Sell |
3,350
-940
| -22% | -$83.1K | 0.16% | 206 |
|
|
2017
Q2 | $390K | Hold |
4,290
| – | – | 0.16% | 204 |
|
|
2017
Q1 | $377K | Hold |
4,290
| – | – | 0.16% | 209 |
|
|
2016
Q4 | $355K | Hold |
4,290
| – | – | 0.16% | 202 |
|
|
2016
Q3 | $397K | Hold |
4,290
| – | – | 0.19% | 184 |
|
|
2016
Q2 | $334K | Hold |
4,290
| – | – | 0.16% | 205 |
|
|
2016
Q1 | $354K | Hold |
4,290
| – | – | 0.17% | 191 |
|
|
2015
Q4 | $449K | Buy |
+4,290
| New | +$448K | 0.22% | 162 |
|
Other funds holding BMRN
BBA